MORTALITY AND MORBIDITY REVIEW POLICY
|
|
- Adela Flynn
- 5 years ago
- Views:
Transcription
1 MORTALITY AND MORBIDITY REVIEW POLICY Document Author Written By: Executive Medical Director Authorised Authorised By: Chief Executive Date: May 2017 Date: 8 th August 2017 Lead Director: Executive Medical Director Effective Date: 8 th August 2017 Review Date: 7 th August 2018 Approval at: Corporate Governance & Risk Sub-Committee Date Approved: 8th August 2017 Page 1 of 22
2 DOCUMENT HISTORY (Procedural document version numbering convention will follow the following format. Whole numbers for approved versions, e.g. 1.0, 2.0, 3.0 etc. With decimals being used to represent the current working draft version, e.g. 1.1, 1.2, 1.3, 1.4 etc. For example, when writing a procedural document for the first time the initial draft will be version 0.1) Date of Issue 20 May March May Aug August 2017 Version. Date Approved Director Responsible for Change May 14 Executive Medical Director 1.1 Executive Medical Director 1.1 Executive Medical Director Aug 17 Executive Medical Director Aug 17 Executive Medical Director Nature of Change Ratification / Approval Final Version Update To be ratified Approved subject to EIA completion for 1 year Update of EIA Approved at Policy Management Group To be ratified at QGC Clinical Standards Group Corporate Governance & Risk Sub-Committee Corporate Governance & Risk Sub-Committee NB This policy relates to the Isle of Wight NHS Trust hereafter referred to as the Trust Page 2 of 22
3 Contents Page 1. Executive Summary 4 2. Introduction 4 3. Definitions 4 4. Scope 5 5. Purpose 5 6. Roles & Responsibilities 5 7. Policy Detail / Course of Action 7 8. Consultation 9 9. Training Monitoring Compliance and Effectiveness Links to other Organisational Documents References Appendices 10 Appendix A Mortality Review Group Terms of Reference 11 Appendix B Mortality Review Template 14 Appendix C Mortality Outlier Rapid Review 16 Appendix D Financial and Resourcing Impact Assessment 18 Appendix E Equality Impact Assessment (EIA) Screening Tool 20 Page 3 of 22
4 1 Executive Summary Routine review of deaths or patients coming to harm or near misses is a vital element of Trust governance promoting safety of care for our patients. Use of Dr Foster Intelligence, The Summary Hospital-level Mortality Indicator (SHMI), monthly review of all deaths, coroner and Serious Incident Requiring Investigation (SIRI) review allows a cross check of performance by the Mortality Review Group, which supports routine surveillance of morality. The Group reports to SEE, QGC and Trust Board. Morbidity data should be reviewed through relevant Clinical Business Unit Quality Groups and then, as necessary, to our Trust overarching Quality Governance Committee. 2 Introduction The policy supports assurance to our patients, staff and Trust Board, that we are continuously reviewing patient outcomes and learning from these, the policy has been developed to ensure that a consistent approach is taken in relation to the methodology used for all Mortality Reviews and to define the assurance mechanism for mortality review in our Trust. 3 Definitions Mortality for the purpose of M&M meetings, mortality relates to any deaths within 30 days of procedure within a surgical specialty or any in hospital unexpected death for non-surgical specialties. Morbidity relates to adverse outcomes Complication an additional problem that arises following a procedure, treatment or illness and is secondary to it / complicates the situation. Misadventure Any injury or adverse reaction resulting from any medical treatment. Some examples are medication errors, IV infection, surgical mistakes and postoperative septicaemia. Serious Incident Requiring Investigation (SIRI) An accident occurring on NHS premises that resulted in serious injury, and or permanent harm, unexpected or avoidable death Avoidable/Preventable These terms are used interchangeably in the NHS and for the purpose of this policy preventable or unpreventable will be used with reference to whether anything could have been done to change the outcome. Page 4 of 22
5 Mortality & Morbidity Meetings (M&Ms) M&M meeting is where a multi-disciplinary group review and discuss clinical cases, outcome data (clinician and patient reported) and related information (e.g. SIRI, complaints, and any other benchmarking data). For the purpose of this policy this includes Radiology Discrepancy Meetings. M&M meetings May be joint M&M/Audit meetings as audit plays an important part in the M&M process. If separate meetings, there will need to be an agreed process for ensuring the findings from both are shared across and any actions suitable co-ordinated 4 Scope This policy applies to all clinical staff in our Trust. The implementation of this policy should be supported by administrative staff and managers as applicable. 5 Purpose The aim of this policy is to ensure: 5.1 A consistency of approach to the review of patient mortality within the Isle of Wight NHS Trust; and for that approach to be multi-disciplinary as appropriate 5.2 The outputs of any such reviews are clearly documents, and reviewed by the Mortality Review Group and reported throughout Trust governance committees 5.3 Appropriate action is taken to investigate any seemingly unacceptable mortality data 5.4 Appropriate action plans are produced and monitored in the event of any identified mortality issues 5.5 Oversee any wider system learning that comes from reviews 6 Roles and Responsibilities The Executive Medical Director is responsible for: Is responsible for ensuring the implementation of the Mortality review process and for developing an overarching framework for our Trust Board. Regularly updating the Mortality Policy to reflect any new developments. Reviewing external mortality data sources and coordinating investigation into any issues unexplained by routine processes. Coordination the weekly Mortality review meeting and monthly Mortality review group. Page 5 of 22
6 The Patient Safety, Experience and Clinical Effectiveness (SEE) Directorate is responsible for: Will hold day to day operational responsibility for ensuring the appropriate application of this policy and processing of the results of local Mortality groups Overseeing the corporate learning from Mortality meetings and providing assurance to Quality and quality governance committee in relation to the Mortality process. Clinical Directors are responsible for: Supporting appropriate multi-disciplinary M&M meetings taking place in all relevant specialities and for holding a list of Mortality and Morbidity meetings within their clinical directorate. In some cases it may be necessary for mortality reviews to be undertaken at an individual level. Establishing a reporting process from Mortality meetings to the clinical directorate Quality, Patient Safety and Risk Meetings. These will then be escalated to the Mortality Review Group. Clinical Leads are responsible for: Ensuring appropriate multi-disciplinary M & M meetings take place in their speciality Identifying an M & M chair. Liaising with the Directorate Management Team to identify relevant administrative support M & M (Audit) Chairs are responsible for ensuring: The appropriate attendance by all relevant disciplines and professional groups. For doctors in training it is a curricular requirement to attend those meetings and actively contribute to them. Monitoring attendance of staff at M & M meetings through maintenance of attendance registers. Relevant case note reviews are undertaken of deceased patients and recorded using agreed templates. Setting the agenda The accurate minutes are taken and archived in line with Information Governance processes. Collation of review findings, learning points and actions for improvement from each M&M meeting Ensuring that any identified Duty of Candour issues are addressed via the responsible clinician. Reporting M&M findings to Directorate Meetings. Escalating up areas of concern. Page 6 of 22
7 Medical staff are responsible for: All medical staff are required to proactively participate fully in the M&M process as appropriate, Morbidity and Mortality figures should form part of annual appraisal process where relevant. All clinical staff are expected to participate fully in all M&M meetings, including those in other trusts where applicable, that are relevant to their practice, this should be integrated in future appraisal and accreditation processes. Staff attending M&M meetings off site have a duty to report back to their local M&M lead any issues that are relevant to this Trust or to them personally. Nurses, Allied Health Professionals and other clinical staff are responsible for: All healthcare professionals should be involved in M&M reviews, as part of their clinical practice. This involvement could range from simply being aware of the outcome of such reviews insofar as they affect their area of practice, to full involvement in the production of data and implementation of recommendations. Directorate Quality and Risk Meetings are responsible for: Supporting the M&M meetings, and providing guidance where necessary for cases requiring review. Outcomes of the M&M meetings/reviews should be overseen by the Quality and Risk meetings. 7 Policy detail/course of Action 7.1 Each M&M Group should identify and confirm with the Clinical / Speciality Lead the following: Chairman Terms of reference Frequency of meetings, ideally should be monthly Membership (multi-disciplinary and multi-professional) Working arrangements of specialty M&M groups and frequency of joint meetings if applicable Reporting arrangements with other Quality / audit groups within the Trust. Arrangements for minutes / notation Mortality inclusion/exclusion criteria for routine patient case note review Morbidity (e.g. complications and misadventures) inclusion/exclusion criteria for routine patient case note review. Mortality Review Template to be used Completion of M&M review templates and collation of finding, learning points and actions from each meeting Storage and retrieval of minutes in line with Information Governance Policies Reporting arrangements including the escalation of concerns to the Executive Medical Director, these will be reviewed at a Quarterly Mortality Review Meeting Page 7 of 22
8 7.2 The following data should be reviewed: Where applicable e.g. Maternity, Paediatrics, Mental Health, Surgery and Orthopaedics All in-hospital deaths, in Medicine sampling may be more relevant. All in-hospital complications, misadventures as identified via the clinician or Datix reporting system Other data relating to mortality and morbidity including complaints, incidents and other benchmarking data Reviewing this data on a monthly basis will enable the areas to identify the number of cases to be reviewed each month i.e. review the Dr Foster data to identify outliers and SHMI to trigger series reviews. 7.3 The following cases should be reviewed individually: All deaths in electively admitted patients (except in cancer and haematology) All deaths in Low Risk Mortality Diagnosis Groups as per Dr Foster Mortality data All paediatric, neonatal and maternal deaths All other deaths as per terms of reference for each M&M meeting Emergency Department Deaths, with the exclusion of those patients who are dead on arrival (DOA) 7.4 In addition the following cases should be considered for review: Patients coded as having had a misadventure Patients coded as having had a complication which led to their death Incidents flagged via the Dr Foster custom alert process. 7.5 Other reviews to be carried out: All SIRIs relating to unexpected death/failure to recognise deteriorating patients/ unexpected complication these are expected to be identified on Datix Cases subject to inquest, where The Trust is likely to be at fault Morbidity and Mortality which has generated a significant patient or relative complaint Any other significant, unexpected morbidity, harm or significant concerns identified by any member of the mutli-disciplinary team/patient/carer, regarding patient outcomes, clinical practice or equipment. 7.6 The following should also be considered by the group: Any related feedback from inquests Any internal or external peer review of cases or benchmarking data (national registries, society of college outcome data etc.) Any other issues attendees wish to raise. 7.7 Weekly Mortality Reviews All deaths occurring in the acute Trust will be reviewed by a multidisciplinary team using a template agreed by the Trust mortality review group (See Appendix A) Concerns found at review will be escalated to the relevant clinical team and will be reviewed by the Trust Mortality review group. Responses will be received by the Page 8 of 22
9 Trust Mortality group. Output from all reviews will be reviewed by the Mortality review group. 7.8 Trust Mortality Review Group The Group will meet monthly in accordance with the Terms of Reference (Appendix B) The group will be chaired by the Medical Director or Deputy Medical Director The group will review the outputs of local M&M reviews as relevant and will receive an annual report from every active Mortality and Morbidity Group each year All deaths of patients under the care of Mental Health and Learning Difficulties triggering a review will be reviewed at the Mortality Review Group The Mortality Review Group will c o o r d i n a t e rapid reviews based on data from CQC, Dr Foster, TDA, and local monthly reviews. These will be recorded on the template attached (Appendix C). Results will be reported to QCPC at the quarterly mortality review and will be shared with relevant stakeholders including CCG. 8 Consultation This policy has been developed in conjunction with the Executive Medical Director and has been consulted on with medical staff and other stakeholders, as well as being available for all Trust staff on the intranet. 9 Training This policy will be implemented by the Clinical Directors in conjunction with the Executive Medical Director and the Patient Safety Experience and Clinical Effectiveness (SEE) Directorate, with relevant support and training provided. This Mortality and Morbidity Review Policy does not have a mandatory training requirement or any other training needs. 10 Monitoring Compliance and Effectiveness 10.1 The Executive Medical Director will oversee the monitoring of this policy Key performance indicators will be: Each speciality will hold M&M meetings, and have agreed terms of reference All areas of concern will be escalated to the Executive Medical Director. Each M&M will report annually to the Trust Mortality Review Group. 11 Links to other Organisational Documents Isle of Wight NHS Trust Information Governance/Risk Policy December 2013 Page 9 of 22
10 12 References The Mid Staffordshire NHS Foundation Trust Inquiry: Independent Inquiry into care provided by Mid Staffordshire NHS Foundation Trust; January 2005 March 2009 Review into the quality of care and treatment provided by 14 hospital trusts in England: Overview Report. Professor Sir Bruce Keogh KBE 13 Appendices Appendix A Mortality Review Group Terms of Reference Appendix B Mortality Review Template Appendix C Mortality Outlier Rapid Review Appendix D Financial and Resourcing Impact Assessment Appendix E Equality Impact Assessment (EIA) Screening Tool Page 10 of 22
11 Appendix A MORTALITY REVIEW GROUP TERMS OF REFERENCE 1. MAIN PURPOSE 1.1 Involve the multidisciplinary team in a critical analysis of the systems and processes leading to an outcome of care. 1.2 Recommend improvements to processes and systems 1.3 Action these recommendations and monitor the results 2. MEMBERSHIP & QUORUM 2.1 Membership of the Group:- Executive Medical Director (Chair) Lead Clinician for Obs & Gynae Lead Clinician for Orthopaedics Lead Clinician for General Surgery Lead Clinician for Urology Lead Clinician for Care of the Elderly Lead Clinician for Anaesthetics Lead Clinician for ICU Lead Clinician for Medicine Lead Clinician for Pathology Associate Medical Director for SEE Associate Medical Director for Medical Education Clinical Coding Manager Patient Experience Lead Representative from Pharmacy Representative from Occupational Therapy Head of Nursing and Quality for Mental Health Clinical Effectiveness Lead Representative from Bereavement 2.2 In attendance Business & Projects Co-ordinator to the EMD (administrative support) Other attendees will be invited as required 2.3 Other members will nominate an appropriate deputy to attend in their absence. Page 11 of 22
12 3. FREQUENCY OF MEETINGS 3.1 Meetings are to be held monthly. 4. ATTENDANCE AT MEETINGS 4.1 It is agreed that all members should attend a minimum of 8 out of the 12 meetings per year. When the Group is discussing specific areas of risk are the responsibility of individuals outside of the Group membership, other attendees will be required to attend in order to present papers or to provide additional information in support of discussions. 5. DELEGATED AUTHORITY 5.1 The Mortality Review Group will provide assurance to the SEE Committee. 6. DUTIES AND ADMINISTRATION 6.1 It is the duty of the Group to uphold the Code of Conduct for NHS Managers, which includes the seven principles of public life (The lan Committee), namely, selflessness, integrity, objectivity, accountability, openness, honesty and leadership, and to maintain the Duty of Candour. 6.2 Furthermore, the Group will endeavour to uphold the principles and values as set out in the NHS Constitution for England, March The Group shall be supported administratively by the Business & Projects Co-ordinator to the Executive Medical Director 6.5 These Terms of Reference will be reviewed annually to ensure that the Group is carrying out its functions effectively. 7. ROLES AND RESPONSIBILITIES Involve the multidisciplinary team in a critical analysis of the systems and processes leading to an outcome of care. Recommend improvements to processes and systems Action these recommendations and monitor the results. Review outcome data (clinician and patient reported) and related information (e.g. incidents, SIRI s, complaints, and other benchmarking data). The focus on discussion will be on process and system change, with the aim of developing recommendations to prevent a similar adverse outcome in the future. The meeting is aimed at team learning and quality improvement and can therefore include staff at all levels of seniority. Action points will be noted for the next agenda and feedback will always be given to ensure that recommended changes are implemented and evaluated. Page 12 of 22
13 8. REPORTING ARRANGEMENTS 8.1 The Mortality Review Group will report directly to the SEE Committee 8.2 The following speciality mortality & morbidity groups will report directly to the Mortality Review Group: Anaesthetics & ICU Orthopaedics Surgical Obs & Gynae Paediatrics Acute Medicine Emergency Medicine (ED/Ambulance) Community Oncology Maternity/NICU 9. MONITORING COMPLIANCE WITH TERMS OF REFERENCE 9.1 These Terms of Reference will be reviewed annually to ensure that the Group is carrying out its functions effectively. Page 13 of 22
14 Appendix B MORTALITY REVIEW TEMPLATE CBU: Speciality: Place of death: Pt ID: DOB: Pt age: Date of admission: Date of death: Date of review: Was this admission a readmission within 30 days? Y/N Consultant at time of death: Reviewer: Discussed with coroner? Y/N/don t know PM done? Y/N/ don t know Inquest? Y/N/ don t know Main diagnosis on admission (first 24 hrs) Confirmed diagnosis (after tests, within first 5 days) Cause of death (use PM data if available) Ia Ib Ic II Have the notes been coded YES /NO /t coded yet Coding inaccuracies either in demographics, type of admission, diagnosis, procedures PART 1. These are questions about your impression of the care given based on information in notes. Please state reason if these questions are N/A (e.g. died quickly in A&E): Were the notes complete enough for you to make an assessment of the patient s journey and care they received? YES NO N/A Was death likely or anticipated at admission either due to acute condition or underlying frailties? YES NO N/A Was death likely due to a condition that was fully diagnosed during their admission? YES NO N/A Was the person reviewed regularly enough? YES NO N/A Were all episodes of deterioration adequately escalated? YES NO N/A Was there anything to suggest that diagnostic investigations were delayed or unavailable and it affected YES NO N/A the quality of the person s care or the clinical outcome? Please include out of hours. Examples include MRI, OGD, CT Was there anything to suggest the person did not have timely access to appropriate consultant-led YES NO N/A interventions that affected that quality of their care of the clinical outcome? Please include out of hours. Examples include angiography, radiological intervention, emergency surgery. Is there anything to suggest iatrogenic illness or injury during the inpatient stay YES NO N/A If surgery occurred, was death directly related to the surgery? YES NO N/A After initial review of notes, are you confident that the care was of an acceptable standard? YES NO N/A Page 14 of 22
15 PART 2. This section asks more detailed questions that are less about your clinical impression and are related to relevant audit standards: Was the person seen and thoroughly assessed by a suitable consultant within 14 hours of arrival at hospital? YES NO N/A Unable to tell While on AMU, SAU, ICU and other high dependency areas, was the person seen and reviewed by a consultant YES NO N/A Unable to tell twice daily, While on a general ward was the person reviewed at least once every 24 hours, seven days a week, unless it had been determined that this would not affect their care pathway? If needed, did the person have scheduled seven-day access to diagnostic services such as x-ray, ultrasound, computerised tomography (CT), magnetic resonance imaging (MRI), echocardiography, endoscopy, bronchoscopy and pathology? with reporting available seven days a week?: Within 1 hour for critical patients Within 12 hours for urgent patients Within 24 hours for non-urgent patients If needed, did the person have timely 24 hour access, seven days a week, to consultant-directed interventions sourced either on-site or through formally agreed networked arrangements with clear protocols, such as: Critical care Interventional radiology Interventional endoscopy Emergency general surgery If the person had been assessed/identified as having palliative care need pre-admission, is your impression from the notes that alternatives to hospital admission might have been more appropriate? (If yes please explain what these were in part 5) PART 3. Using your answers from Part 1 and 2, please circle the appropriate mortality outcome. YES NO N/A Unable to tell YES NO N/A Unable to tell YES NO N/A Unable to tell YES NO N/A Unable to tell Death expected refers to whether we expected them to die and/or recognised that they were at high risk of death in the days leading up to death, even if it had not been expected at admission. Optimal care broadly means that they were regularly reviewed by a senior clinician, there were no delays in investigation or treatment, that care was adequately escalated and that they did not suffer any iatrogenic illness or injury. Death expected Death not expected Optimal medical care 1 2 Suboptimal clinical care 3 4 PART 4. If death was unexpected, tick here and go on to part 5. Complete for all expected deaths, even if it was not anticipated on admission. Was CPR and the escalation plan discussed and documented with either person or relatives? YES NO N/A Was the preferred place of death identified? YES NO N/A Was it recognised that the person was actually dying in the hours or days before death? YES NO N/A Had active treatment with the intent to cure stopped and symptom control becomes the focus? YES NO N/A Was the responsible consultant involved in that decision? YES NO N/A Was the Priorities of care plan (PCP) used while they were dying? (if they died within 48 hrs of active treatment stopping please circle N/A ) YES NO N/A Once it was recognised they were dying, was the person reviewed every 24 hours as per national YES NO N/A guidance (regardless of whether they were on PCP, does not have to be by consultant) If they were symptomatic while dying, were they seen by the palliative care team? YES NO N/A While dying was consideration given to artificial hydration and nutrition YES NO N/A PART 5. Bearing in mind your responses so far, please complete the following section re next steps. further action required, other than routine feedback to M&M meeting, tick if applies: OR Further action required: Follow-up PM or inquest outcome Ask responsible consultant or other relevant staff to comment on certain issues, please list who and what those issues are: Tick if requested Date when completed Other issues, please specify: Page 15 of 22
16 Mortality Outlier Rapid Review Appendix C Issue Identified: Review undertaken by: Date: Method: Results Overview: Breakdown: 1. Coding Error 2. Coding correct, but coincidental to case of death 3. Coding correct, was not primary cause of death but part of demise 4. Coding was correct cause of death Extended case review requested number of cases Page 16 of 22
17 Overview of each case: Further Issues for review: Insert Spreadsheet Report forwarded to: Page 17 of 22
18 Appendix D Financial and Resourcing Impact Assessment on Policy Implementation NB this form must be completed where the introduction of this policy will have either a positive or negative impact on resources. Therefore this form should not be completed where the resources are already deployed and the introduction of this policy will have no further resourcing impact. Document title Totals WTE Recurring n Recurring Manpower Costs Training Staff Equipment & Provision of resources Summary of Impact: Risk Management Issues: Benefits / Savings to the organisation: Equality Impact Assessment Has this been appropriately carried out? YES Are there any reported equality issues? NO If YES please specify: Use additional sheets if necessary. Please include all associated costs where an impact on implementing this policy has been considered. A checklist is included for guidance but is not comprehensive so please ensure you have thought through the impact on staffing, training and equipment carefully and that ALL aspects are covered. Manpower WTE Recurring n-recurring Operational running costs Totals: Staff Training Impact Recurring n-recurring Totals: Version 2.1 Page 18 of 22
19 Equipment and Provision of Resources Recurring * n-recurring * Accommodation / facilities needed Building alterations (extensions/new) IT Hardware / software / licences Medical equipment Stationery / publicity Travel costs Utilities e.g. telephones Process change Rolling replacement of equipment Equipment maintenance Marketing booklets/posters/handouts, etc Totals: Capital implications 5,000 with life expectancy of more than one year. Funding /costs checked & agreed by finance: Signature & date of financial accountant: Funding / costs have been agreed and are in place: Signature of appropriate Executive or Associate Director: Version 2.1 Page 19 of 22
20 Appendix E Equality Impact Assessment (EIA) Screening Tool Document Title: Purpose of document Target Audience A consistency of approach to the review of patient mortality within the Isle of Wight NHS Trust Medical Staff Person or Committee undertaken the Equality Impact Assessment Mortality Review Group 1. To be completed and attached to all procedural/policy documents created within individual services. 2. Does the document have, or have the potential to deliver differential outcomes or affect in an adverse way any of the groups listed below? If no confirm underneath in relevant section the data and/or research which provides evidence e.g. JSNA, Workforce Profile, Quality Improvement Framework, Commissioning Intentions, etc. If yes please detail underneath in relevant section and provide priority rating and determine if full EIA is required. Positive Impact Negative Impact Reasons Gender Men Women Asian or Asian British People Race Black or Black British People Chinese people People of Mixed Race Version 2.1 Page 20 of 22
21 White people (including Irish people) People with Physical Disabilities, Learning Disabilities or Mental Health Issues Sexual Orientat ion Age Transgender Lesbian, Gay men and bisexual Children 0-18 Older People (60+) Younger People (18 to 24 yrs.) Faith Group Pregnancy & Maternity Equal Opportunities and/or improved relations tes: Faith groups cover a wide range of groupings, the most common of which are Buddhist, Christian, Hindus, Jews, Muslims and Sikhs. Consider faith categories individually and collectively when considering positive and negative impacts. The categories used in the race section refer to those used in the 2001 Census. Consideration should be given to the specific communities within the broad categories such as Bangladeshi people and the needs of other communities that do not appear as separate categories in the Census, for example, Polish. 3. Level of Impact If you have indicated that there is a negative impact, is that impact: Legal (it is not discriminatory under anti-discriminatory law) YES NO Intended If the negative impact is possibly discriminatory and not intended and/or of high impact then please complete a thorough assessment after completing the rest of this form. Version 2.1 Page 21 of 22
22 3.1 Could you minimise or remove any negative impact that is of low significance? Explain how below: 3.2 Could you improve the strategy, function or policy positive impact? Explain how below: 3.3 If there is no evidence that this strategy, function or policy promotes equality of opportunity or improves relations could it be adapted so it does? How? If not why not? Scheduled for Full Impact Assessment Name of persons/group completing the full assessment. Date Initial Screening completed Date: Version 2.1 Page 22 of 22
Medical Devices Management Policy
Document Author Written By: Medical Devices Co-ordinator Date: 07/02/17 Lead Director: Exectuve Director of Nursing & Quality Authorised Authorised By: Chief Executive Date: 11/04/2017 Effective Date:
More informationPOLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007:
POLICY FOR THE IMPLEMENTATION OF SECTION 132 OF THE MENTAL HEALTH ACT (MHA) 1983 AS AMENDED BY THE MHA 2007: PROVISION OF INFORMATION TO DETAINED PATIENTS Document Author Written By: Lead for Mental Health
More informationORAL ANTI-CANCER THERAPY POLICY
ORAL ANTI-CANCER THERAPY POLICY Document Author Written By: Lead Oncology Pharmacist Authorised Authorised By: Chief Executive Officer Date: vember 2016 Date: 11 th April 2017 Lead Director: Executive
More informationCHILDREN S OBSERVATIONS & SEVERITY TOOL (COAST FORMELY PEWS) & PAEDIATRIC OBSERVATION CHART POLICY
CHILDREN S OBSERVATIONS & SEVERITY TOOL (COAST FORMELY PEWS) & PAEDIATRIC OBSERVATION CHART POLICY Document Author Written By: Paediatric Sister Authorised Authorised By: Chief Executive Date: July 2017
More informationREVALIDATION FOR REGISTERED NURSES AND MIDWIVES
REVALIDATION FOR REGISTERED NURSES AND MIDWIVES Document Author Written By: Deputy Director of Nursing Date: 25 February 2016 Lead Director: Executive Director of Nursing Authorised Authorised By: Chief
More informationNew Clinical Procedures, Interventions, Techniques or Expanded Practice Policy, Introduction of
New Clinical Procedures, Interventions, Techniques or Expanded Practice Policy, Introduction of Document Author Written By: Clinical Director for Surgery, Women and Children s CBU Authorised Authorised
More informationClinical Review, Hospital at Night and Handover Policy
Clinical Review, Hospital at Night and Handover Policy Document Author Written By: Clinical Director (Surgery, Women s and Children s Health) and Hospital at Night Working Group Authorised Authorised By:
More informationMENTAL HEALTH ACT SECTION 17 LEAVE POLICY
MENTAL HEALTH ACT SECTION 17 LEAVE POLICY Document Author Written By: MHA & MCA Lead Authorised Authorised By: Chief Executive Date: February 2018 Date: 13 th March 2018 Lead Director: Director for Mental
More informationClinical Supervision Policy
Clinical Supervision Policy Document Author Written By: Consultant Nurse Authorised Authorised By: Chief Executive Date: 07.06.2016 Date: 13 th December 2016 Lead Director: Executive Director of Effective
More informationCOMMUNITY TREATMENT ORDER POLICY MENTAL HEALTH ACT 2007 SECTION 17A
COMMUNITY TREATMENT ORDER POLICY MENTAL HEALTH ACT 2007 SECTION 17A Document Author Written By: MHA & MCA Lead Authorised Authorised By: Chief Executive Date: June 2017 Lead Director: Clinical Director,
More informationClinical Coding Policy
Clinical Coding Policy Document Author Written By: Clinical Coding Manager Authorised Authorised By: Chief Executive Date: February 2017 Lead Director: Executive Director of Financial and Human Resources
More informationMORTALITY REVIEW POLICY
MORTALITY REVIEW POLICY Version 1.3 Version Date July 2017 Policy Owner Medical Director Author Associate Director of Patient Safety & Quality First approval or date last reviewed July 2017 Staff/Groups
More informationLearning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care.
Learning from Deaths Policy A Framework for Identifying, Reporting, Investigating and Learning from Deaths in Care. Associated Policies Being Open and Duty of Candour policy CG10 Clinical incident / near-miss
More informationPolicy on Learning from Deaths
Trust Policy Policy on Learning from Deaths Key Points Mortality review is an important part of our Safety and Quality Improvement Process. All patients who die in our trust have a review of their care.
More informationLearning from Deaths Policy LISTEN LEARN ACT TO IMPROVE
Learning from Deaths Policy LISTEN LEARN ACT TO IMPROVE EQUALITY IMPACT The Trust strives to ensure equality and opportunity for all, both as a major employer and as a provider of health care. This policy
More informationAppendix 1 MORTALITY GOVERNANCE POLICY
Appendix 1 MORTALITY GOVERNANCE POLICY 1 Policy Title: Executive Summary: Mortality Governance Policy For many people death under the care of the NHS is an inevitable outcome and they experience excellent
More informationLearning from Deaths Policy
Learning from Deaths Policy The Learning from Deaths Policy sets out the minimum acceptable standards of the national learning from deaths programme. Policy group General Document Detail Version 1 Approved
More informationLearning from Deaths Policy. This policy applies Trust wide
Learning from Deaths Policy This policy applies Trust wide Document control page Name of policy Learning from Deaths Policy Names of linked Learning from Deaths Procedure procedures Accountable Medical
More informationSWH Mortality Review Policy
Corporate Governance SWH 01785 The Trust s Intranet holds the current approved guidance documents. Notice to staff using a paper copy of this document. Staff must ensure that they are using the most up-to-date
More informationTRUST CORPORATE POLICY RESPONDING TO DEATHS
SCOPE OF APPLICATION AND EXEMPTIONS CONSULT ATION COR/POL/224/2017-001 TRUST CORPORATE POLICY RESPONDING TO DEATHS APPROVING COMMITTEE(S) EFFECTIVE FROM DISTRIBUTION RELATED DOCUMENTS STANDARDS OWNER AUTHOR/FURTHER
More informationMARSIPAN POLICY. Management of Really Seriously ill People with Anorexia Nervosa
MARSIPAN POLICY Management of Really Seriously ill People with Anorexia Nervosa Document Author Written By: Clinical Director, Mental Health & Learning Disability Services Date: August 2015 Authorised
More informationReport to the Board of Directors 2015/16
Attachment 9 Report to the Board of Directors 2015/16 Date of meeting 18 Subject Report of Prepared by Seven Day Services Medical Director Ashling Rivá, Project Manager Previously considered by Transformation
More informationSAFEGUARDING CHILDREN & YOUNG PEOPLE POLICY
SAFEGUARDING CHILDREN & YOUNG PEOPLE POLICY Document Author Written By: Named Nurse/Midwife for Safeguarding Children Authorised Authorised By: Chief Executive Date: 21 January 2016 Date: 7 April 2016
More informationMoving to 7 Day Services. Kerry Gant, Head of Finance Change Team/Debbie Freake, Executive Director of Strategy
Report to Trust Board of Directors Date of Meeting: 24 March 2015 Enclosure Number: 12 Title of Report: Author: Executive Lead: Responsible Sub- Committee (if appropriate): Executive Summary: Moving to
More informationPolicy Summary. Policy Title: Policy and Procedure for Clinical Coding
Policy Title: Policy and Procedure for Clinical Coding Reference and Version No: IG7 Version 6 Author and Job Title: Caroline Griffin Clinical Coding Manager Executive Lead - Chief Information and Technology
More informationApproval at:policy Management Group Date Approved: 15 December 2015
INFECTION PREVENTION AND CONTROL BLOOD CULTURE COLLECTION POLICY Document Author Written By: IPC doctor Authorised Authorised By: Chief Executive Date: October 2015 Date: 15 December 2015 Lead Director:
More informationLearning from Deaths Framework Policy
Learning from Deaths Framework Policy Profile Version: 1.0 Author: Dr Nigel Kennea, Associate Medical Director (Mortality) Executive/Divisional sponsor: Medical Director Applies to: All staff Date issued:
More informationSeven Day Services Clinical Standards September 2017
Seven Day Services Clinical Standards September 2017 11 September 2017 Gateway reference: 06408 Patient Experience 1. Patients, and where appropriate families and carers, must be actively involved in shared
More informationh. HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST LEARNING FROM DEATHS POLICY. Broad Recommendations / Summary
201 2017.473h. HULL AND EAST YORKSHIRE HOSPITALS NHS TRUST LEARNING FROM DEATHS POLICY Broad Recommendations / Summary In-hospital death occurs. Patient 18 years of age or above. Yes Child Death Review
More informationMortality Policy - Learning from Deaths (CG627)
Mortality Policy - Learning from Deaths (CG627) Approval Approval Group Job Title, Chair of Committee Date Policy Approval Group Chair, Policy Approval Group September 2017 Change History Version Date
More informationLearning from Deaths; Mortality Review Policy
Learning from Deaths; Mortality Review Policy Version: 4.0 New or Replacement: Replacement Policy number: CESC/2012/066 (Version 4) Document author(s): Executive Sponsor: Non-Executive Sponsor: Title of
More informationLearning from Deaths Policy
Policy Author: Owner: Publisher: Version: 1 Peter Wanklyn, Helen Noble Medical Director Medical Governance Date of version issue: September 2017 Approved by: Executive Board Date approved: September 2017
More informationLinen and Laundry Policy
Document Author Written By: Hotel Services Manager Date: 15 May 2017 Authorised Authorised By: Chief Executive Date: 12th September 2017 Lead Director: Director for Strategy and Planning Effective Date:
More informationLearning from Deaths Policy
Learning from Deaths Policy Document Reference No. CLIN041v4 Version No. 4 Issue Date 16/11/2017 Review Date 1 st September 2020 Document Author Document Owner Accountable Executive Approved by Deputy
More informationMortality Policy. Learning from Deaths
Mortality Policy Learning from Deaths Name of Author and Job Title: Frank Jacobs, Datix project manager Ian Brandon, Head of governance and risk Name of Review/ Development Body: Ratification Body: Mortality
More informationLEARNING FROM DEATHS POLICY
Issue number: 1st Edition LEARNING FROM DEATHS POLICY Author with contact details Dr Neil Mercer, Associate Medical Director for Clinical Governance Neil.mercer@aintree.nhs.uk tel. 529-5152 Original Issue
More informationDocument Title Investigating Deaths (Mortality Review) Policy
Document Title Investigating Deaths (Mortality Review) Policy Document Description Document Type Policy Service Application DWMH Trust wide Version 1.0 Policy Reference no. POL 351 Lead Author(s) Name
More informationManagement of Diagnostic Testing and Screening Procedures Policy
Trust Policy Management of Diagnostic Testing and Screening Procedures Policy Purpose Date Version July 2012 2 The purpose of this policy is to ensure that all diagnostic and screening tests undertaken
More informationDIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY
DIAGNOSTIC CLINICAL TESTS AND SCREENING PROCEDURES MANAGEMENT POLICY (To be read in conjunction with Diagnostic Imaging Requesting and Interpreting Radiographs by Non Medical Practitioners Policy, Consent
More informationSurrey & Sussex Healthcare NHS Trust. Learning from Deaths (Mortality Review) Policy
Surrey & Sussex Healthcare NHS Trust Learning from Deaths (Mortality Review) Policy Status (Draft/ Ratified): Ratified Date ratified: 14/09/2017 Version: 1 Ratifying Board: Effectiveness Committee Approved
More informationDELIVERING THE LONDON QUALITY STANDARDS AND 7 DAY SERVICES
Enclosure I DELIVERING THE LONDON QUALITY STANDARDS AND 7 DAY SERVICES Trust Board Meeting Item: 13 Date: 25 th May 2016 Purpose of the Report: Enclosure: I To update the Board on the Trust s current performance
More informationAgenda Item: REPORT TO PUBLIC BOARD MEETING 31 May 2012
Agenda Item: 5.1.1 REPORT TO PUBLIC BOARD MEETING 31 May 2012 Title Lead Director Author(s) Purpose Previously considered by Ratification of the Strategy for the Care of Older People Siobhan Jordan, Director
More informationLearning from the Deaths of Patients in our Care Policy
Learning from the Deaths of Patients in our Care Policy Approved By: Date of Original Approval: UHL Mortality Review Committee UHL Policies & Guidelines Committee September 2017 Trust Reference: B31/2017
More informationTuberculosis (TB) Diagnosis and Management Policy for the Isle of Wight
Tuberculosis (TB) Diagnosis and Management Policy for the Isle of Wight Document Author Written By: Consultant Respiratory Physician, TB Lead Date: October 2016 Authorised Authorised By: Chief Executive
More informationSOUTH CENTRAL AMBULANCE SERVICE NHS FOUNDATION TRUST RISK, HEALTH AND SAFETY POLICY. Being Open and Duty of Candour Policy
SOUTH CENTRAL AMBULANCE SERVICE NHS FOUNDATION TRUST RISK, HEALTH AND SAFETY POLICY Being Open and Duty of Candour Policy DOCUMENT INFORMATION Author: Debbie Marrs Deputy Director of Quality and Patient
More informationAdult Observation Chart Policy (Incorporating National Early Warning Score NEWS)
Adult Observation Chart Policy (Incorporating National Early Warning Score NEWS) Document Author Written By: Sister Critical Care Outreach Service Authorised Authorised By: Chief Executive Date: 1 st April
More informationPolicy on Learning from Deaths
Policy on Learning from Deaths Version number: 1 Consultation: Governance Committee Board Committee Director of Quality Assistant Director of Governance & Compliance Patient Safety Manager Ratified by:
More informationASEPTIC NON TOUCH TECHNIQUE (ANTT) POLICY
ASEPTIC NON TOUCH TECHNIQUE (ANTT) POLICY Infection Prevention & Control Document Author Written By: Infection Prevention & Control Team Date: 1 st April 2018 Lead Director: Director of Nursing Authorised
More informationCOMPLAINTS, CONCERNS AND COMPLIMENTS POLICY
COMPLAINTS, CONCERNS AND COMPLIMENTS POLICY Document Author Written By: Patient Eperience Lead Authorised Authorised By: Chief Eecutive Date: 30 November 2015 Lead Director: Eecutive Director of Nursing
More informationCentral Alerting System (CAS) Policy
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray
More informationDelivering Improvement in Practice
v Delivering Improvement in Practice NHS Providers Governance Conference 7 July 2016 Sir Mike Aaronson Chairman, Frimley Health NHS Foundation Trust 2006-2016 Frimley Health FT Comprises: Frimley Park
More informationLone worker policy. Director of Nursing Therapies Patient Partnership Author and contact number Safety and Security Lead
Document level: Trustwide (TW) Code: GR33 Issue number: 3 Lone worker policy Lead executive Director of Nursing Therapies Patient Partnership Author and contact number Safety and Security Lead 01244 397618
More informationPaediatric Observation and Assessment Unit Operational Policy
Paediatric Observation and Assessment Unit Operational Policy 1 Policy Title: Paediatric Observation and Assessment Unit Operational Policy Executive Summary: Supersedes: Description of Amendment(s): This
More informationLEARNING FROM DEATHS (Mortality Policy)
LEARNING FROM DEATHS () Version: 1.0 Date issued: October 2017 Review date: September 2020 Applies to: All Clinical Staff Groups This document is available in other formats, including easy read summary
More informationMedicines Reconciliation Policy
Medicines Reconciliation Policy Lead executive Medical Director Authors details Senior Clinical Pharmacy Technician - 01244 39 7494 Document level: Trustwide (TW) Code: MP19 Issue number: 3 Type of document
More informationLearning From Deaths Policy
Learning From Deaths Policy The purpose of this policy is to provide a systematic approach to ensure that the Trust has robust governance arrangements in place to review, report and learn from patient
More informationHospital Generated Inter-Speciality Referral Policy Supporting people in Dorset to lead healthier lives
NHS Dorset Clinical Commissioning Group Hospital Generated Inter-Speciality Referral Policy Supporting people in Dorset to lead healthier lives PREFACE This Document outlines the CCG s policy in respect
More informationTRAUMA UNIT OPERATIONAL POLICY
TRAUMA UNIT OPERATIONAL POLICY Document Author Written By: TARN Co-ordinator Authorised Authorised By: Chief Executive Date: 28/08/2016 Date: 13 th December 2016 Lead Director: Medical Director Effective
More informationEvidence Search Completed by..joanne Phizacklea.Date
Document Type: Procedure Unique Identifier: CORP/PROC/073 Document Title: Mortality Review Process Scope: Consultants, Nursing Staff, Clinical Coding Staff, Clinical Audit & Effectiveness Staff, Quality
More informationDiagnostic Testing Procedures in Urodynamics V3.0
V3.0 09 01 18 Table of Contents Summary.... 1. Introduction... 3 1.1. Diagnostic testing information... 3 2. Purpose of this Policy/Procedure... 3 2.1. Approved Document Process... 3 3. Scope... 3 3.1.
More informationRBCH Actions to meet CQC Essential Standards
RBCH Actions to meet CQC Essential Standards REGULATION 17 How the regulation was not being met Patients, their relatives, and staff told us about incidents where people had not been treated with dignity
More informationPAEDIATRIC SURGERY AND ANAESTHESIA POLICY. Safe Provision of
PAEDIATRIC SURGERY AND ANAESTHESIA POLICY Safe Provision of Document Author Written By: Paediatric Charge Nurse in conjunction with Consultant Anaesthetist and Consultant Surgeon ENT, on behalf of the
More informationDate 4 th September 2015 Dr Ruth Charlton, Joint Medical Director / Jill Down, Associate Director of Quality Laura Rowe, Compliance Manager
TB 099/15 Meeting title Report title Trust Board Risk Management Strategy Date 4 th September 2015 Lead director Report author FOI status Dr Ruth Charlton, Joint Medical Director / Jill Down, Associate
More informationMULTIDISCIPLINARY MEETINGS FOR COMMUNITY HOSPITALS POLICY
MULTIDISCIPLINARY MEETINGS FOR COMMUNITY HOSPITALS POLICY (To be read in conjunction with Handover Policy) Version: 3 Ratified by: Date ratified: August 2015 Title of originator/author: Title of responsible
More informationClinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist within RCHT. 1. Aim/Purpose of this Guideline
Clinical Guideline for Clinical Imaging Referral Protocol for Upper & Lower GI Non medical Endoscopist. 1. Aim/Purpose of this Guideline 1.1 This protocol applies to upper & lower GI Non medical Endoscopist
More informationMortality Monitoring Policy
Mortality Monitoring Policy Document Information Version: 3.0 Date: 25/07/2016 Ratified by: King s Executive Date ratified: 31 July 2017 Author(s): Responsible Director: Responsible committee: Date when
More informationTrust Board Meeting: Wednesday 13 May 2015 TB
Trust Board Meeting: Wednesday 13 May 2015 Title Update on Quality Governance Framework Status History For information, discussion and decision This paper has been presented to Quality Committee in April
More information1.3 Referrer: in the context of this protocol the term referrer refers to a health care worker who is authorised to refer individuals for X-rays.
Clinical Guideline for Clinical Imaging Referral Protocol for Nurse Endoscopist (Lower GI) within the Royal Cornwall Hospitals Trust 1. Aim/Purpose of this Guideline 1.1 This protocol applies to Nurse
More informationPATIENTS WITH DIARRHOEA
PATIENTS WITH DIARRHOEA Infection Prevention and Control Policy: Document Author Written By: Infection Prevention & Control Team Date: September 2015 Lead Director: Executive Directorate of Nursing Authorised
More informationEquality and Diversity strategy
Equality and Diversity strategy 2016-2019 DRAFT If you would like this document in a different format, please telephone 0117 9474400 or e-mail getinvolved@southgloucestershireccg.nhs.uk Executive Summary
More informationLearning from Deaths Policy
Learning from Deaths Policy Version: 3 Approved by: Board of Directors Date Approved: October 2017 Lead Manager: Associate Medical Director for Patient Safety and Clinical Risk Responsible Director: Medical
More informationDate ratified November Review Date November This Policy supersedes the following document which must now be destroyed:
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Cleaning Policy NTW(O)71 James Duncan Deputy Chief Executive / Executive Director of Finance Steve Blackburn Deputy
More informationDiagnostic Test Reporting & Acknowledgement Procedures. - Pathology & Clinical Imaging
Diagnostic Test Reporting & Acknowledgement Procedures V2.0 November 2014 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5.
More informationThe Royal Wolverhampton Hospitals NHS Trust
The Royal Wolverhampton Hospitals NHS Trust Trust Board Report Meeting Date: 24 October 2011 Title: Executive Summary: Action Requested: Report of: Author: Contact Details: Resource Implications: Public
More informationNHS England (Wessex) Clinical Senate and Strategic Networks. Accountability and Governance Arrangements
NHS England (Wessex) Clinical Senate and Strategic Networks Accountability and Governance Arrangements Version 6.0 Document Location: This document is only valid on the day it was printed. Location/Path
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Named Key Worker for Cancer Patients Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Named Key Worker for Cancer Patients Policy Version No.: 4 Effective 07 December 2017 From: Expiry Date: 07 December 2020 Date Ratified: 17 October
More informationRTT Assurance Paper. 1. Introduction. 2. Background. 3. Waiting List Management for Elective Care. a. Planning
RTT Assurance Paper 1. Introduction The purpose of this paper is to provide assurance to Trust Board in relation to the robust management of waiting lists and timely delivery of elective patient care within
More informationUnique Identifier: Review Date: November Issue Status: Approved Version No: 1.4 Issue Date: November 2017
Policy Authors Name & Title: Dr Mark Jackson, Director of Research & Informatics Dr Raphael Perry, Medical Director Scope: Trust Wide Classification: Non Clinical Replaces: version 1.3 To be read in conjunction
More informationThis SLA covers an enhanced service for care homes for older people and not any other care category of home.
Care Homes for Older People Service Level Agreement 2016-2019 All practices are expected to provide essential and those additional services they are contracted to provide to all their patients. This service
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Implementation Policy for NICE Guidelines
The Newcastle upon Tyne Hospitals NHS Foundation Trust Implementation Policy for NICE Guidelines Version No.: 5.3 Effective From: 08 May 2017 Expiry Date: 02 March 2019 Date Ratified: 23 February 2017
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Introduction and Development of New Clinical Interventional Procedures
The Newcastle upon Tyne Hospitals NHS Foundation Trust Introduction and Development of New Clinical Interventional Procedures Version No.: 2.1 Effective From: 27 November 2017 Expiry Date: 7 January 2019
More informationPARTICULARS, SCHEDULE 2 THE SERVICES, A Service Specification. 12 months
E09/S(HSS)/b 2013/14 NHS STANDARD CONTRACT FOR VEIN OF GALEN MALFORMATION SERVICE (ALL AGES) PARTICULARS, SCHEDULE 2 THE SERVICES, A Service Specification Service Specification No. Service Commissioner
More informationAuthor: Kelvin Grabham, Associate Director of Performance & Information
Trust Policy Title: Access Policy Author: Kelvin Grabham, Associate Director of Performance & Information Document Lead: Kelvin Grabham, Associate Director of Performance & Information Accepted by: RTT
More informationExecutive Director of Nursing and Chief Operating Officer
Document Title Arrangements for Managing Patients Mental and Physical Health Needs across NTW and the Acute Hospital Trusts Reference Number Lead Officer Author(s) (name and designation) Ratified by NTW(C)15
More informationMortality Report Learning from Deaths. Quarter
Mortality Report Learning from Deaths Quarter 3 2017 Introduction In December 2016 the CQC report Learning, Candour and accountability: A review of the way NHS Trusts review and investigate the deaths
More informationNUTRITION / HYDRATION POLICY TO PREVENT & MANAGE MALNUTRITION & DEHYDRATION IN ADULTS
NUTRITION / HYDRATION POLICY TO PREVENT & MANAGE MALNUTRITION & DEHYDRATION IN ADULTS Document Author Written By: Clinical Nutrition Nurse Specialist Authorised Authorised By: Chief Executive Date: 16
More informationSOUTH CENTRAL AMBULANCE SERVICE NHS FOUNDATION TRUST
SOUTH CENTRAL AMBULANCE SERVICE NHS FOUNDATION TRUST EDUCATION POLICY & PROCEDURE (EPP No.04) CLINICAL SUPERVISION OF PATIENT FACING and CLINICAL PATIENT CONTACT STAFF DURING TRAINING POLICY This policy
More informationDiagnostic Testing Procedures in Neurophysiology V1.0
V1.0 10 September 2012 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities... 3 5.2. Role of the
More informationAccess to Health Records Procedure
Access to Health Records Procedure Version: 1.0 Ratified by: Date ratified: 11/03/2015 Name of originator/author: Name of responsible individual: Information Governance Group Medical Records Manager, Jackie
More informationHEALTH & SAFETY. Management of Health & Safety Policy
NHS TAYSIDE HEALTH & SAFETY Management of Health & Safety Policy Author: Chief Executive Review Group: Strategic Risk/ Management Group Review Date: January 2014 Last Update: January 2013 Document : HS/03
More informationDischarge Policy for Paediatric Patients from the Children s Unit
Discharge Policy for Paediatric Patients from the Children s Unit Policy : Discharge Policy for Paediatric Patients from the Children s Unit Executive Summary Intended to work alongside the East Cheshire
More informationLearning from Deaths, Mortality Review Policy
Learning from Deaths, Mortality Review Policy Policy Number: 981 Version: 1.0 Category Authorisation Committee/Group Clinical Patient Safety Committee Date of Authorisation: 29 th August 2017 Ratification
More informationPolicy for the Management of Safety Alerts issued via the Central Alerting System (CAS)
Policy for the Management of Safety Alerts issued via the Central Alerting System (CAS) Policy Title: Executive Summary: Policy for the Management of Safety Alerts issued via the Central Alerting System
More informationEast Cheshire NHS Trust VitalPAC Business Continuity
East Cheshire NHS Trust VitalPAC Business Continuity Page 1 Document Title: Executive Summary: This plan provides clear instructions on Business Continuity when VitalPAC functions are unavailable Supersedes:
More informationBereavement Policy. 1 Purpose of Policy 2. 2 Background 2. 3 Staff Responsibilities 3. 4 Operational Issues and Local Policies/Protocols/Guidelines 4
Trust Policy and Procedure Bereavement Policy Document Ref. No: PP(16)252 For use in: For use by: For use for: Document owner: Status: All areas of the Trust All Trust staff The dying, their relatives
More informationNON-MEDICAL PRESCRIBING POLICY
NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August
More informationand colonisation suppression POLICIES REPLACING N/A
TITLE: UNIQUE IDENTIFIER Assigned by Sharepoint VERSION No 1.2 LEAD AUTHOR S NAME Allison Charlesworth LEAD AUTHOR JOB TITLE Matron Infection Prevention ACCOUNTABLE DIRECTOR Rob Dearden, Director of Nursing
More informationStatus: Information Discussion Assurance Approval. Claire Gorzanski, Head of Clinical Effectiveness
Report to: Trust Board Agenda item: Date of Meeting: 2 October 2017 SFT3934 Report Title: Annual quality governance report 2016-2017 Status: Information Discussion Assurance Approval X Prepared by: Executive
More informationAHRC FIRST WORLD WAR PUBLIC ENGAGEMENT CENTRES. Research Fund Guidance Notes
AHRC FIRST WORLD WAR PUBLIC ENGAGEMENT CENTRES Research Fund Guidance Notes OVERVIEW The five AHRC First World War Engagement Centres can provide funding to support members of their research networks working
More informationJob Description. Job title: Gynae-Oncology Clinical Nurse Specialist Band: 7. Department: Cancer Services Hours: 30
Job Description Job title: Gynae-Oncology Clinical Nurse Specialist Band: 7 Department: Cancer Services Hours: 30 Reports to: Lead Nurse for Cancer We are a pioneering research active organisation and
More information